Internal Server Error

Endofotonics - About the company

Endofotonics is a series B company based in Singapore (Singapore), founded in 2014 by Cheng Tim Kum and Huang Zhi Wei. It operates as a Raman spectroscopy-based endoscopic system. Endofotonics has raised $8.5M in funding from Seeds Capital and ZIG Ventures. The company has 138 active competitors, including 43 funded and 14 that have exited. Its top competitors include companies like Scholar Rock, SamanTree Medical and Lucida Medical.

Company Details

Endophotonics is a medical device company that has developed an endoscopic system based on Raman Spectroscopy. The IMDX system consists of a Raman Spectroscope, a proprietary specially designed fibre-optic confocal Raman endoscopic probe that comprises a central light delivery fibre for laser light delivery and collection fibres for in vivo tissue Raman signal collection of tissue spectra and can be inserted into the instrument channel of conventional endoscopes and a proprietary control software that enables epithelial molecular information to be extracted and analyzed in real-time. Spectral information acquired by the system is matched against a database to quick diagnosis.
Email ID
*****@endofotonics.com
Registered Address
79 AYER RAJAH CRESCENT #04-05 SINGAPORE 139955
Key Metrics
Founded Year
2014
Location
Singapore, Singapore
Stage
Series B
Total Funding
$8.5M in 2 rounds
Latest Funding Round
Ranked
Employee Count
2 as on Apr 30, 2026
Similar Companies
Sign up to download Endofotonics' company profile

Endofotonics's funding and investors

Endofotonics has raised a total funding of $8.5M over 2 rounds. Its first funding round was on 2016. Endofotonics has 3 institutional investors and 21 angel investors.

Here is the list of recent funding rounds of Endofotonics:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 28, 2020
6374308
Series B
7298101
3157359
5024082
9556529
2016
8654
Series A
5986
2437
4105
lockAccess funding benchmarks and valuations. Sign up today!

Endofotonics' founders and board of directors

Founder? Claim Profile
The founders of Endofotonics are Cheng Tim Kum and Huang Zhi Wei. Cheng Tim Kum and Peter Cheng are the CEOs of Endofotonics.
Here are the details of Endofotonics' key team members:

Endofotonics' Board of Directors

Endofotonics's board has 6 active members. Cheng Tim Kum and Kwong Hwa Jen are part of team and Sim Kok Hwee, Tony tan Choon Keat, Beng Teck Liang and Professor Lui Pao Chuen are independent board members.
Here is the list of Endofotonics' board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
9y 6m
zueykev
Team
-
Current
5y 7m
Independent board member
-
Current
9y 6m
sgbsejp
Independent board member
-
Current
7y 9m
awsvhhb
Independent board member
-
Current
3y 2m
tqqxplc
Independent board member
-
Current
9y 7m
xfsprix
Independent board member
-
Past
5y 8m
ninffoj
Independent board member
-
Past
4y 4m
batbldl
Independent board member
-
Past
1y 8m
xqcdtnu
Independent board member
-
Past
7y 1m

Endofotonics' employee count trend

Endofotonics has 2 employees as of Apr 26. Here is Endofotonics's employee count trend over the years:
Employee count trend for Endofotonics
lockUncover Endofotonics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Endofotonics's Competitors and alternates

Top competitors of Endofotonics include Scholar Rock, SamanTree Medical and Lucida Medical. Here is the list of Top 10 competitors of Endofotonics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Scholar Rock
Scholar Rock
2012, Cambridge (United States), Public
Developer of Antibody-based drugs for the treatment of primary myopathies
$103M
61/100
2nd
Logo for SamanTree Medical
SamanTree Medical
2014, Lausanne (Switzerland), Series C
Developer of digital microscopy system for high-resolution imaging of tissue
$57.5M
58/100
3rd
Logo for Lucida Medical
Lucida Medical
2019, Cambridge (United Kingdom), Series A
Developer of MRI-based cancer screening technology using artificial intelligence (AI)
$11.5M
58/100
4th
Logo for Sysmex
Sysmex
1968, Kobe (Japan), Public
Developer of diagnostic instruments, reagents, and related software
-
-
54/100
5th
Logo for Perfint Healthcare
Perfint Healthcare
2005, Chennai (India), Series D
Developer of solutions for image-guided interventional procedures
$41.5M
54/100
6th
Logo for Ionpath
Ionpath
2014, Menlo Park (United States), Series B
Developer of an imaging platform for tissue biopsies
$18M
53/100
7th
Logo for RAYDIAX
RAYDIAX
2021, Magdeburg (Germany), Series A
Developer of therapy-assist CT system for minimally invasive interventions
$8.4M
52/100
8th
Logo for NeoCura
NeoCura
2017, Changping (China), Series A
Provider of an AI-enabled immunotherapy based tumor diagnostic platform
$38.2M
52/100
9th
Logo for Adiposs
Adiposs
2018, Geneva (Switzerland), Series A
Developer of medical imaging equipment for the diagnosis of cachexia
$7.25M
51/100
10th
Logo for Windtree Therapeutics
Windtree Therapeutics
1992, Philadelphia (United States), Public
Developer of therapies for oncology and cardiovascular diseases with unmet needs
$45K
51/100
41st
Logo for Endofotonics
Endofotonics
2014, Singapore (Singapore), Series B
Raman spectroscopy-based endoscopic system
$8.5M
36/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Endofotonics's competitors? Click here to see the top ones

Endofotonics's Investments and acquisitions

Endofotonics has made no investments or acquisitions yet.

News related to Endofotonics

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Endofotonics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford